A total of 42 strains of Haemophilus influenzae type b isolated from pediatric patients were sensitive in vitro to temocillin (90% minimal inhibitory concentration = 0.25 ,ug/ml). No difference in mean minimal inhibitory concentration between ,B-lactamase producer (0.25 ,ug/ml) and nonproducer (0.23 jig/ml) strains was found. Various dosages of ampicillin or temocillin for the treatment of infant rats with ampicillin-resistant H. influenzae bacteremia and meningitis yielded no difference in cure rates. These results suggest that temocillin may not be as effective as other new cephalosporins for the treatment of H. influenzae type b infections.
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Temocillin (BRL 17421), a new semisynthetic P-lactam antibiotic, has recently been shown to be active in vitro against most aerobic gramnegative organisms, including a wide range of 1B-lactamase producers (4) . In addition, the bactericidal activity of this compound against Haemophilus influenzae was found to be good (3). These properties suggest that temocillin might be suitable for the treatment of serious H. influenzae type b infections in childhood. The purpose of this study was to evaluate in vitro the activity of temocillin against clinical isolates of H. influenzae type b and to compare in vivo temocillin and ampicillin against ampicillin-resistant H. influenzae type b bacteremia and meningitis in the infant rat model. A total of 42 H. influenzae type b strains isolated from the blood or cerebrospinal fluid (CSF) of pediatric patients were studied. Identification, serotyping, and biotyping were performed by methods previously described (8) . 1-lactamase activity was determined by pH changes due to penicilloic acid production from penicillin (2) . The minimal inhibitory concentration (MIC) and the minimal bactericidal concentration of temocillin against each strain were determined, as previously described (6) . Dilu inhibited at a concentration of 0.25 ,.g/ml. No difference in MIC between 3-lactamase-positive (14 strains) and -negative (28 strains) strains was found (mean ± standard deviation was 0.25 ± 0.12 and 0.23 + 0.07 ,ug/ml, respectively). The minimal bactericidal concentrations were identical to or one tube higher than the MICs for all strains. Susceptibility to temocillin was not influenced by increasing the inoculum size from 104 to 106 CFU per ml. These results confirm previous reports that H. influenzae is inhibited by temocillin at a concentration of <0.5 ,ug/ml (4, 5) and that there is no difference in MIC against either 3-lactamase-positive or -negative strains (5) .
In vivo experiments used the infant rat model of bacteremia and meningitis as previously described (7). Animals were injected intraperitoneally with 104 CFU of ampicillin-resistant H. influenzae type b (strain Bloch) in 0.1 ml (MIC = 12.5 ,ug/ml). Blood and CSF cultures were taken 36 h after inoculation by procedures described previously (7) . By the method used, the lower limit of detectable bacteria was 200 CFU per ml. Twelve infected animals were injected intraperitoneally with a single dose of 100 mg of temocillin per kg. Blood and CSF samples were obtained at 30, 90, 180, and 360 min after injection. After CSF samples demonstrating visible blood contamination were discarded, six animals remained in the study group. Temocillin concentrations were measured by a standard disk agar diffusion bioassay with Pseudomonas aeruginosa (BRL 2134) as the seed organism. The lowest concentration which could reliably be measured was 4 j.g/ml. The peak blood concentration at 30 min ( Fig. 1) Moxon et al. (3) . This may be explained by the high serum and CSF levels of ampicillin achieved (290 and 27 p.g/ml, respectively) (3), which are severalfold greater than the MIC required for inhibition of the offending organism. Since a 100% cure rate was achieved with 100-mg doses of either temocillin or ampicillin per kg, lower doses were used. With doses of each drug of 50 mg/kg there was initial clearance of bacteremia and meningitis, but recrudescence in both treatment groups occurred at 54 h posttherapy, showing no statistically significant differences in cure rates between temocillin and ampicillin. When doses of each drug of 25 mg/kg were used, temocillin seemed to be more effective at 6 h posttreatment. More animals were free of bacteria in blood or CSF compared with ampicillin (P < 0.01 and P < 0.05, respectively). A 1-to 2-log reduction in CFU per milliliter was observed in all remaining animals with positive blood and CSF cultures. In contrast, when the rats were recultured 54 h after cessation of therapy, many animals showed recrudescence of their infection both in blood and CSF with no statistical difference between the two treatment groups. The differences in elimination half-lives between ampicillin (0.6 h) (3, 7) and temocillin (1.0 h) may 
